Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Transplant Proc ; 45(10): 3620-3, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-24314976

RESUMO

BACKGROUND: Infectious disease, a complication favored by immunosuppression, is the main cause of 1st-year mortality in solid organ transplantation. In renal transplant recipients (RTRs), urinary tract infection (UTI) is the most common, and the microorganisms that are isolated depend on chronology. METHODS: We present an observational study comprising 129 RTRs from January 2010 to December 2011 who were followed during the 1st year after transplantation. We analyzed occurrence of infections, predisposing factors, timing, severity, site of infection, and microorganisms. RESULTS: The patients had a total of 424 infectious episodes during the 1st year (3.29 episodes/patient/year). The predominant focus was the urinary tract, with at least 1 episode in 69.8% of patients. Bacteremia was recorded in 25.6% of patients and surgical wound infection in 20.9%. Cytomegalovirus infection or disease was diagnosed in 46.5%. Severe infections occurred in 30.2%. The predominant pathogen was E. coli. There was a significant correlation between hospital stay and the number of infections (P = .000; r = 0.407) and between body mass index and hospital stay (P = .001; r = 0.282). Severe infections were more frequent in diabetics, patients with a double-J stent, and those treated with basiliximab. Patients with cytomegalovirus replication had a higher number of infections (4.1 ± 1.2 vs 2.5 ± 5; P = .000) and significantly higher annual serum creatinine (1.65 ± 5.7 vs 1.31 ± 1.3 mg/dL; P = .003). CONCLUSIONS: The prevalence of infections in the 1st year after kidney transplantation is very high, occurring mainly in the early period, in the urinary tract, and due to E. coli. Cytomegalovirus replication is associated with a higher number of infections and higher serum creatinine at 1 year. Body mass index is a predictor of early infection and of bacteremia in the post-transplantation period. Basiliximab induction and having a double-J stent were predictors of severe infections.


Assuntos
Doenças Transmissíveis/epidemiologia , Transplante de Rim/efeitos adversos , Adulto , Anticorpos Monoclonais/efeitos adversos , Basiliximab , Biomarcadores/sangue , Índice de Massa Corporal , Doenças Transmissíveis/diagnóstico , Doenças Transmissíveis/microbiologia , Doenças Transmissíveis/virologia , Creatinina/sangue , Infecções por Citomegalovirus/epidemiologia , Infecções por Citomegalovirus/virologia , Complicações do Diabetes/etiologia , Infecções por Escherichia coli/epidemiologia , Infecções por Escherichia coli/microbiologia , Humanos , Imunossupressores/efeitos adversos , Tempo de Internação , Masculino , Prevalência , Proteínas Recombinantes de Fusão/efeitos adversos , Fatores de Risco , Índice de Gravidade de Doença , Espanha , Stents/efeitos adversos , Fatores de Tempo , Resultado do Tratamento , Infecções Urinárias/epidemiologia , Infecções Urinárias/microbiologia , Infecções Urinárias/virologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...